Azacitidine-venetoclax versus azacitidine salvage treatment for primary induction failure or first relapsed acute myeloid leukaemia patients.
Petit C, Saillard C, Mohty B, Hicheri Y, Villetard F, Maisano V, Charbonnier A, Rey J, D'Incan E, Rouzaud C, Gelsi-Boyer V, Murati A, Lhoumeau AC, Ittel A, Mozziconacci MJ, Alary AS, Hospital MA, Vey N, Garciaz S.
Petit C, et al.
Eur J Haematol. 2024 Apr;112(4):530-537. doi: 10.1111/ejh.14140. Epub 2023 Nov 29.
Eur J Haematol. 2024.
PMID: 38031389